Scheme 1From: Folate-modified liposomes mediate the co-delivery of cisplatin with miR-219a-5p for the targeted treatment of cisplatin-resistant lung cancerFA-modified Lipo nanomaterials co-deliver DDP and miR-219a-5p to NSCLC cells, effectively inducing apoptosisBack to article page